The FDA assessed the safety and performance of atidarsagene autotemcel based upon facts from 37 little ones who obtained atidarsagene autotemcel in two one-arm, open-label clinical trials As well as in an expanded access method.[7] Children who gained remedy with atidarsagene autotemcel were being a